<?xml version="1.0" encoding="UTF-8"?><Articles><Article><id>447</id><JournalTitle>EPAC INVOLVED IN INFLAMMATORY AND REMODELING PROCESSES IN ASTHMA: A REVIEW</JournalTitle><Abstract>Asthma is a chronic inflammatory disease of the airways. Airway hyperresponsiveness, inflammation and
remodeling is the typical characteristics of the disease. Currently, the development and mechanism of a disease has not been
fully elucidated. Cyclic adenosine monophosphate (cAMP) is an important second messenger in- vivo. A variety of
pathophysiological processes including calcium signaling, inflammation, cell growth and differentiation, and apoptosis is
involved in the regulation of human metabolism. For a long time, protein kinase A (PKA) was considered to be the only
signaling molecule and now the cAMP is another molecule which mediated biological effect. However, the new target
molecule exchange protein directly activated cAMP(Epac) have found to break this statement. Numerous studies
confirm,Epac may be used alone or in combination with PKA. cAMP plays a variety of biological effects. In this paper, the
role of Epac in the occurrence and development of bronchial asthma is reviewed and also providing a theoretical basis for the
study of new asthma treatments</Abstract><Email>sujansayami84@yahoo.com</Email><articletype>Review</articletype><volume>6</volume><issue>1</issue><year>2016</year><keyword>Bronchial asthma,cAMP,Epac,PKA</keyword><AUTHORS>Sujan Prakash Manandhar,Gao Ya Dong</AUTHORS><afflication>Department of Pulmonology, Zhongnan Hospital, The Second affiliated hospital of the School of Medicine of Wuhan University, Wuhan, 430072, China,Department of Pulmonology, Zhongnan Hospital, The Second affiliated hospital of the School of Medicine of Wuhan University, Wuhan, 430072, China</afflication></Article></Articles>